Insights

AI in Life Sciences Talking Medicines specializes in turning unstructured health data into actionable intelligence using Advanced Data Science and AI platforms like DrugVoice and PeopleVoice, presenting a strong value proposition for pharma, med comms agencies, and life sciences leaders seeking measurable marketing impact.

Measurement Driven DrugVoice provides a structured way to measure messaging resonance, sentiment shifts, and prescribing intent across the drug lifecycle, enabling clients to optimize strategy, creative, and demonstrate hard value to stakeholders.

Employee Insights PeopleVoice surfaces real internal sentiment and experience data to improve wellbeing, retention, and performance, offering cross-sell opportunities into HR and internal comms functions in life sciences or pharma organizations.

Growth & Expansion Recent financing activity and international expansion signals, including US office growth and recognition in UK AI indices, suggest a trajectory of increasing scale and potential for deeper enterprise engagements and larger deals.

Market Positioning Awards and industry recognition (PM360 Trailblazer, Elite 100) alongside inclusion in UK AI Index 2026 enhance credibility for selling to large pharma, agencies, and global Life Sciences customers seeking validated AI-enabled insights.

Similar companies to Talking Medicines

Talking Medicines Tech Stack

Talking Medicines uses 8 technology products and services including Google Ads, LinkedIn Ads, Power BI, and more. Explore Talking Medicines's tech stack below.

Media & News

Talking Medicines's Email Address Formats

Talking Medicines uses at least 4 email formats:
Talking Medicines Email FormatsExamplePercentage
First@talkingmedicines.comJohn@talkingmedicines.com
88%
Last@talkingmedicines.comDoe@talkingmedicines.com
7%
FirstLast@talkingmedicines.comJohnDoe@talkingmedicines.com
3%
First.Last@talkingmedicines.comJohn.Doe@talkingmedicines.com
2%

Frequently Asked Questions

What is Talking Medicines's official website and social media links?

Minus sign iconPlus sign icon
Talking Medicines's official website is talkingmedicines.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Talking Medicines generate?

Minus sign iconPlus sign icon
As of August 2026, Talking Medicines's annual revenue is estimated to be $1M - $10M.

What is Talking Medicines's SIC code and NAICS code?

Minus sign iconPlus sign icon
Talking Medicines's SIC code is 7299 - Miscellaneous Personal Services, Not Elsewhere Classified and NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does Talking Medicines have currently?

Minus sign iconPlus sign icon
As of August 2026, Talking Medicines has approximately 27 employees across 3 continents, including Europe, Asia and North America. Key team members include Chief Executive Officer, Founder: J. H. M., Coo/Cdo, Founder: E. F. and Founder: S. C. Explore Talking Medicines's employee directory with LeadIQ.

What industry does Talking Medicines belong to?

Minus sign iconPlus sign icon
Talking Medicines operates in the Technology, Information and Internet industry.

What technology does Talking Medicines use?

Minus sign iconPlus sign icon
Talking Medicines's tech stack includes Google Ads, LinkedIn Ads, Power BI, Amazon Web Services, Mailchimp, HubSpot, Piwik and Vimeo.

What is Talking Medicines's email format?

Minus sign iconPlus sign icon
Talking Medicines's email format typically follows the pattern of First@talkingmedicines.com. Find more Talking Medicines email formats with LeadIQ.

How much funding has Talking Medicines raised to date?

Minus sign iconPlus sign icon
As of August 2026, Talking Medicines has raised $4.6M in funding. The last funding round occurred on May 26, 2026 for $2M.

When was Talking Medicines founded?

Minus sign iconPlus sign icon
Talking Medicines was founded in 2013.
Talking Medicines logo

Talking Medicines

Technology, Information and InternetNew Jersey, United States11-50 Employees

Talking Medicines applies data science to life sciences, converting unstructured health data into actionable insights that demonstrate the impact of marketing efforts. The company operates two platforms, DrugVoice and PeopleVoice, designed to help Life Sciences and corporate leaders make evidence-based decisions by understanding how messaging resonates and influences behavior. Based in Jersey City, New Jersey, it positions itself in the technology, information, and internet space and serves a range of life sciences customers with a data-driven approach.

DrugVoice enables pharmaceutical companies and medical communications agencies to evaluate the effectiveness of scientific messaging throughout the drug lifecycle, using a metrics framework to reveal which narratives resonate with healthcare professionals and how sentiment and prescribing intent change over time. PeopleVoice, by contrast, focuses on internal workforce signals, turning employee sentiment into measurable insights that support wellbeing, retention, and performance. The organization has expanded its footprint to the United States in 2022 and has earned recognition in 2026 as a top UK AI company, reflecting its growing profile in AI-enabled life sciences analytics.

Section iconCompany Overview

SIC Code
7299 - Miscellaneous Personal Services, Not Elsewhere Classified
NAICS Code
5415 - Computer Systems Design and Related Services
Founded
2013
Employees
11-50

Section iconFunding & Financials

  • $4.6M

    Talking Medicines has raised a total of $4.6M of funding over 5 rounds. Their latest funding round was raised on May 26, 2026 in the amount of $2M as a Convertible Note.

  • $1M - $10M

    Talking Medicines's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.